On January 3, 2019 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, reported that it will participate at the Biotech Showcase 2019 conference and the BIO One-on-One Partnering @ JPM 2019, taking place between Monday, January 7th and Wednesday, January 9th, that will be held in San Francisco, California in parallel to the JP Morgan Healthcare Conference (Press release, Can-Fite BioPharma, JAN 3, 2019, View Source [SID1234532375]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sari Fishman, VP of Business Development, will host partnering meetings at the two conferences with biotech and pharmaceutical companies.

Can-Fite’s near term milestones include data release from a Phase II study with its Namodenoson drug in patients with advanced liver cancer which is expected in Q1/19. In addition, the Company is actively enrolling NAFLD/NASH patients for a Phase II study of Namodenoson.

On January 2, 2019 Alexion Pharmaceuticals (Nasdaq: ALXN) reported that management will present at the (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437])9 at 7:30 a.m., PT (Press release, Alexion, JAN 2, 2019, View Source [SID1234532437]). A breakout question and answer session will immediately follow the formal presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Audio webcasts of the presentation and breakout question and answer session will be available live. You can access the webcasts at: View Source An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.

On January 2, 2019 LabCorp (NYSE: LH) reported it will participate at the 37th Annual J.P. Morgan Healthcare Conference (Press release, LabCorp, JAN 2, 2019, View Source;p=RssLanding&cat=news&id=2381927 [SID1234532436]). LabCorp’s presentation is scheduled for Tuesday, January 8, 2019 at 1:30 p.m. (PT), followed by a question and answer session at 2:00 p.m. (PT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation and the subsequent question and answer session will be available via the Company website at www.labcorp.com and archived for replay.

On January 2, 2019 Novavax, Inc. (Nasdaq:NVAX) reported that it will present at the 37th Annual J.P. Morgan Healthcare Conference (Press release, Novavax, JAN 2, 2019, View Source [SID1234532400]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details are as follows:

Date and time:Wednesday, January 9, 3:00 p.m. – 3:25 p.m. P.T.
Location:Colonial Room, Westin St. Francis Hotel, San Francisco
Live webcast:www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section of the website at www.novavax.com.

On January 2, 2019 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) reported that management will present at the J.P. Morgan Healthcare Conference onMonday, January 7, 2019 at 2:30 p.m. ET (11:30 a.m. PT) (Press release, Vertex Pharmaceuticals, JAN 2, 2019, View Source [SID1234532399]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The audio portion of management’s remarks can be accessed live through Vertex’s website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company’s website.